Funding is highly influenced by how well a company’s intellectual property is protected. Quality patents and a well-planned portfolio strategy can make all the difference. Developing an attractive IP profile is a deliberate and complex process. For life sciences companies, collaboration between management, scientists, and patent professionals is essential to building a strong position that is compelling to investors.
Our panel brings together perspectives from in-house, outside, and investor’s counsel—all with extensive patent experience—to discuss particular issues and nuances related to patent strategies for life sciences startups. Topics to be addressed include:
Finnegan and 5AM Ventures are pleased to cohost this program. We hope you will join us for an insightful and interactive discussion.
Who Should Attend: Patent professionals and anyone with responsibility for/interest in protecting or investing in a company’s intellectual property.
RSVP: Please register by Friday, November 7, 2014. There is no charge to attend.
MCLE Credit: Finnegan confirms that this activity has been certified for 1.0 hour of California MCLE credit.
Ronald A. Krasnow, General Counsel, Senior Vice President
Relypsa, Inc.
Leslie A. McDonell, Partner
Finnegan
Paul A. Stone, General Counsel & Chief Operating Officer
5AM Ventures
M. Paul Barker, Partner
Finnegan
Wednesday, November 12, 2014
2:15-2:30 p.m. - Registration
2:30-4:30 p.m. - Presentation
4:30-6:00 p.m. - Reception
Finnegan
Stanford Research Park
3300 Hillview Avenue
Palo Alto, CA 94304
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Webinar
Building a Strong ADC Patent Portfolio – From Prosecution and Litigation Perspectives
May 15, 2024
Webinar
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.